Ad Alert

Blissoma

The FDA is far from blissed-out about this skin care company's health claims.

The FDA does not take an ignorance is bliss approach when it comes to Only FDA-approved drugs can be marketed as having the ability to diagnose, cure, treat, prevent or mitigate a disease..

In a July 6 warning letter to St. Louis-based Blissoma, the FDA cited more than a dozen illegal health statements on Blissoma.com, several of which related to claims about prized ingredients in the company’s serums and creams. These included:

Remember, readers, marketing products as having the ability to treat, cure, alleviate the symptoms of, or prevent developing diseases and disorders is simply not permitted by law without FDA approval. If a product really could do all that, then it would be a drug subject to rigorous study and testing to gain FDA approval.

Find more of our coverage on skin care here.


Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.


You Might Be Interested In

Enlifta

Ad Alert

Enlifta

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.